Harmony Biosciences Holdings, Inc. (HRMY)
28.29
-0.22
(-0.77%)
USD |
NASDAQ |
Mar 06, 16:00
28.28
-0.01
(-0.04%)
After-Hours: 20:00
Harmony Biosciences Holdings Cash from Investing (TTM) : -39.65M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Castle Biosciences, Inc. | -60.37M |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Amicus Therapeutics, Inc. | -46.43M |
| Iovance Biotherapeutics, Inc. | 47.50M |
| Apellis Pharmaceuticals, Inc. | -0.313M |